Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Array BioPharma Announces Collaboration with Merck for KEYTRUDA

      Array BioPharma Announces Collaboration with Merck for KEYTRUDA

      Ruby Khatun Khatun11 May 2017 11:55 AM IST
      BOULDER: Array BioPharma Inc. announced today that it has entered into a clinical trial collaboration agreement with Merck (known as MSD outside the...
      Tramadol worth 75 million dollar from Indian company meant for IS seized: Report

      Tramadol worth 75 million dollar from Indian company meant for IS seized: Report

      Ruby Khatun Khatun11 May 2017 11:53 AM IST
      LONDON: A shipload of tramadol, a synthetic opioid-like drug used as painkiller, sent from India to be sold to Islamic State terrorists in Libya to...
      Natco Pharma launches pomalidomide capsules in India

      Natco Pharma launches pomalidomide capsules in India

      Ruby Khatun Khatun11 May 2017 11:50 AM IST
      New Delhi: Natco Pharma said it has launched a generic version of pomalidomide capsules, used in treatment of a type of blood cancer, in...
      Lyca Group launches daycare facility in Chennai

      Lyca Group launches daycare facility in Chennai

      Ruby Khatun Khatun11 May 2017 11:45 AM IST
      Chennai: London-based Lyca Group, which has presence in various businesses, today forayed into the domestic health care segment with the launch of...
      Johnson & Johnson discloses U.S. probe related to arthritis drugs

      Johnson & Johnson discloses U.S. probe related to arthritis drugs

      Ruby Khatun Khatun11 May 2017 10:12 AM IST
      Healthcare conglomerate Johnson & Johnson said on Monday the U.S. Justice Department has opened an investigation concerning management and...
      Mandira Bedi launches healthcare products of Planet Herbs Lifesciences at Herbal Science Summit

      Mandira Bedi launches healthcare products of Planet Herbs Lifesciences at Herbal Science Summit

      Ruby Khatun Khatun11 May 2017 9:12 AM IST
      New Delhi: A leading wellness and healthcare company in Sri Lanka, Russia and the UAE has launched its products in India at The Herbal Science Summit...
      EpiPens should work at least a while past expiration dates, says study

      EpiPens should work at least a while past expiration dates, says study

      Ruby Khatun Khatun11 May 2017 9:12 AM IST
      By Ronnie Cohen(Reuters Health) - It’s worth a shot to use an expired EpiPen, if that’s all you have, a new study suggests.For more than four years...
      Pharma Co Jubilant Life Sciences fined Rs 50 Lakh for pollution in UP

      Pharma Co Jubilant Life Sciences fined Rs 50 Lakh for pollution in UP

      Ruby Khatun Khatun10 May 2017 12:22 PM IST
      New Delhi: The National Green Tribunal has slapped a fine of Rs 50 lakh on five units of Amroha-based drug firm Jubilant Life Sciences for discharging...
      Aurobindo Pharma gets USFDA notice on 7 violations with drug making at Hyderabad unit

      Aurobindo Pharma gets USFDA notice on 7 violations with drug making at Hyderabad unit

      Ruby Khatun Khatun10 May 2017 12:15 PM IST
      Mumbai: The US Food and Drug Administration (FDA) has issued form 483 to Aurobindo Pharma Ltd’s unit-IV in Hyderabad with seven observations relating...
      Pfizer immuno-oncology drug wins U.S. approval for bladder cancer

      Pfizer immuno-oncology drug wins U.S. approval for bladder cancer

      Ruby Khatun Khatun10 May 2017 12:15 PM IST
      U.S. health regulators on Tuesday granted accelerated approval for Pfizer Inc's immuno-oncology drug Bavencio to treat advanced bladder cancer,...
      Abbott and its Smartphone Compatible Insertable Cardiac Monitor

      Abbott and its Smartphone Compatible Insertable Cardiac Monitor

      Ruby Khatun Khatun10 May 2017 10:51 AM IST
      ABBOTT PARK, Ill: Abbott today announced CE Mark and first use of the new Confirm Rx™ Insertable Cardiac Monitor (ICM), the world's first smartphone...
      Samsung Launches Versatile Ultrasound Systems Designed to Enhance the User Experience

      Samsung Launches Versatile Ultrasound Systems Designed to Enhance the User Experience

      Ruby Khatun Khatun10 May 2017 9:25 AM IST
      Samsung’s HS50 and HS60 strengthen the existing Ultrasound portfolio and bring the image quality and advanced technologies from their high-end systems...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok